AU2016372510B2 - Dietary peptides - Google Patents

Dietary peptides Download PDF

Info

Publication number
AU2016372510B2
AU2016372510B2 AU2016372510A AU2016372510A AU2016372510B2 AU 2016372510 B2 AU2016372510 B2 AU 2016372510B2 AU 2016372510 A AU2016372510 A AU 2016372510A AU 2016372510 A AU2016372510 A AU 2016372510A AU 2016372510 B2 AU2016372510 B2 AU 2016372510B2
Authority
AU
Australia
Prior art keywords
seq
artificial
prt
sequence
peptide sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2016372510A
Other languages
English (en)
Other versions
AU2016372510A1 (en
Inventor
Erik Torngaard Hansen
Randi JESSEN
Johan PALMFELDT
Jan STAGSTED
Jiehui ZHOU
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Diet4life Aps
Original Assignee
Diet4life Aps
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Diet4life Aps filed Critical Diet4life Aps
Publication of AU2016372510A1 publication Critical patent/AU2016372510A1/en
Application granted granted Critical
Publication of AU2016372510B2 publication Critical patent/AU2016372510B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/03—Organic compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4716—Muscle proteins, e.g. myosin, actin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/57509—Corticotropin releasing factor [CRF] (Urotensin)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/332—Promoters of weight control and weight loss
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2016372510A 2015-12-16 2016-12-16 Dietary peptides Active AU2016372510B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP15200440.4 2015-12-16
EP15200440 2015-12-16
PCT/EP2016/081572 WO2017103200A1 (en) 2015-12-16 2016-12-16 Dietary peptides

Publications (2)

Publication Number Publication Date
AU2016372510A1 AU2016372510A1 (en) 2018-06-28
AU2016372510B2 true AU2016372510B2 (en) 2021-07-08

Family

ID=55068774

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2016372510A Active AU2016372510B2 (en) 2015-12-16 2016-12-16 Dietary peptides

Country Status (11)

Country Link
US (2) US11259554B2 (enExample)
EP (1) EP3390425B1 (enExample)
JP (1) JP7117779B2 (enExample)
KR (1) KR102863433B1 (enExample)
CN (1) CN108473535A (enExample)
AU (1) AU2016372510B2 (enExample)
BR (1) BR112018012353A2 (enExample)
MX (1) MX2018007212A (enExample)
RU (1) RU2018125630A (enExample)
WO (1) WO2017103200A1 (enExample)
ZA (1) ZA201804124B (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3938037A1 (en) * 2019-03-15 2022-01-19 Diet4Life ApS Combination of dietary peptides
US20230042729A1 (en) * 2019-03-15 2023-02-09 Diet4Life Aps Peptide constructs and compositions

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090117578A1 (en) * 2007-11-05 2009-05-07 Battelle Memorial Institute Method for identifying type I diabetes mellitus in humans
WO2010063124A1 (en) * 2008-12-05 2010-06-10 Angiochem Inc. Peptide therapeutic conjugates and uses thereof
WO2011005893A2 (en) * 2009-07-07 2011-01-13 Abbott Laboratories Biomarkers and methods for detecting alzheimer's disease

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0848634A (ja) 1994-08-05 1996-02-20 Akio Okamoto 角膜治療剤
US7214786B2 (en) 2000-12-14 2007-05-08 Kovalic David K Nucleic acid molecules and other molecules associated with plants and uses thereof for plant improvement
US20090082265A1 (en) * 2002-01-04 2009-03-26 Myriad Genetics, Incorporated Compositions and methods for treating diseases
GB0612623D0 (en) * 2006-06-26 2006-08-02 Ares Trading Sa Proteins
ES2777652T3 (es) * 2006-12-21 2020-08-05 H Lundbeck As Modulación de la actividad de proneurotrofinas
KR101003364B1 (ko) * 2008-04-24 2011-01-07 대한민국 한우 등심 판별용 바이오 마커 단백질
GB201001333D0 (en) 2010-01-27 2010-03-17 Imp Innovations Ltd Novel compounds and their effects on feeding behaviour
WO2011119484A1 (en) 2010-03-23 2011-09-29 Iogenetics, Llc Bioinformatic processes for determination of peptide binding
EP3048904A2 (en) 2013-09-25 2016-08-03 Pronutria Biosciences, Inc. Compositions and formulations for treatment of gastrointestinal tract malabsorption diseases and inflammatory conditions and methods of production and use thereof
WO2017100700A2 (en) * 2015-12-11 2017-06-15 Fred Hutchinson Cancer Research Center Peptides for renal therapy
EP3938037A1 (en) * 2019-03-15 2022-01-19 Diet4Life ApS Combination of dietary peptides
US20230042729A1 (en) * 2019-03-15 2023-02-09 Diet4Life Aps Peptide constructs and compositions

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090117578A1 (en) * 2007-11-05 2009-05-07 Battelle Memorial Institute Method for identifying type I diabetes mellitus in humans
WO2010063124A1 (en) * 2008-12-05 2010-06-10 Angiochem Inc. Peptide therapeutic conjugates and uses thereof
WO2011005893A2 (en) * 2009-07-07 2011-01-13 Abbott Laboratories Biomarkers and methods for detecting alzheimer's disease

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
Abiko, T and Takamura, Y. "Syntheses Of Neurotensin (NT) Analogues And Their Comparative Anorectic Effect On Food Intake In Rats", Protein and Peptide Letters. 2001, vol. 8(6), pages 461-468. *
Einsiedel, J, et al., "Discovery of Highly Potent and Neurotensin Receptor 2 Selective Neurotensin Mimetics", Journal of Medicinal Chemistry. 2011, vol. 54, pages 2915-2923. *
Einsiedel, J, et al., "Peptide Backbone Modifications on the C-Terminal Hexapeptide of Neurotensin", Bioorganic & Medicinal Chemistry Letters. 2008, vol. 18, pages 2013-2018. *

Also Published As

Publication number Publication date
US12295397B2 (en) 2025-05-13
KR20180087433A (ko) 2018-08-01
ZA201804124B (en) 2024-11-27
EP3390425C0 (en) 2024-08-07
AU2016372510A1 (en) 2018-06-28
RU2018125630A3 (enExample) 2020-02-26
RU2018125630A (ru) 2020-01-20
BR112018012353A2 (en) 2018-12-04
US20180368459A1 (en) 2018-12-27
MX2018007212A (es) 2018-11-09
JP7117779B2 (ja) 2022-08-15
US20220248736A1 (en) 2022-08-11
CA3007436A1 (en) 2017-06-22
EP3390425A1 (en) 2018-10-24
US11259554B2 (en) 2022-03-01
CN108473535A (zh) 2018-08-31
EP3390425B1 (en) 2024-08-07
WO2017103200A1 (en) 2017-06-22
NZ743368A (en) 2025-08-29
KR102863433B1 (ko) 2025-09-23
JP2019505572A (ja) 2019-02-28

Similar Documents

Publication Publication Date Title
JP5068174B2 (ja) Ｄｐｐ−ｉｖを阻害するペプチド中に濃縮されたタンパク質の加水分解物及びその使用
Xu Bioactive peptides in milk and their biological and health implications
Sharma et al. Bioactive peptides: a review
Wang et al. A new frontier in soy bioactive peptides that may prevent age‐related chronic diseases
Meisel Biochemical properties of peptides encrypted in bovine milk proteins
Moughan et al. Food-derived bioactive peptides–a new paradigm
CA2669524C (en) Collagen peptide composition and food or beverage containing the same
KR20160056941A (ko) 당뇨병 및 비만의 예방 및 치료를 위한 조성물 및 제형, 그리고 글루코스 및 열량 제어에서 이들의 생성방법 및 용도
US20090270309A1 (en) Use of lactoferrin fragments and hydrolysates
US12295397B2 (en) Dietary peptides
KIM et al. Novel angiotensin-I-converting enzyme inhibitory peptides derived from recombinant human αs1-casein expressed in Escherichia coli
US20230042729A1 (en) Peptide constructs and compositions
US20170112890A1 (en) Peptides and Compositions Thereof for Improvement of Glycaemic Management in a Mammal
US20220315632A1 (en) Combination of dietary peptides
van der Schaaf et al. Proteolysis of lactoferrin and β-casein in complex coacervate and uncomplexed forms during in vitro infant gastrointestinal digestion
CA3007436C (en) Dietary peptides
AU2012210013C1 (en) Sense-improving agent
KR20150110529A (ko) 포만 호르몬 방출 활성을 갖는 신규 폴리펩티드
CN121358342A (zh) 提升的乳质
XU Department of Zoology The University of Hong Kong, Hong Kong
HK1132280A (en) Collagen peptide composition and food or beverage containing the same
TW200902046A (en) Agents for preventing renal failure

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)